Contact UsCareersNewsScienceContact Us
News & Media

Discover our presence in global media here

HomeNewsPRESS RELEASES

2021

June 4, 2021
Pfizer supports deployment of 400 oxygen beds for adult and pediatric patients in Delhi and ICU beds in Mumbai COVID care facilities
May 26, 2021
Pfizer Limited revenue from operations for the quarter and year ended March 31, 2021 at ₹535 crore and ₹2,239 crore respectively

2020

November 2, 2020
Pfizer Limited revenue from operations at ₹595 crores for the quarter ended September 30, 2020
July 27, 2020
Pfizer Limited revenue from operations at ₹515 crores for the quarter ended June 30, 2020
June 15, 2020
Pfizer Limited revenue from operations at ₹502 crore for the quarter ended March 31, 2020

VIEW ALL

PFIZER IN NEWS

2021

1. FDA authorises Pfizer vaccine for teens

Business Standard - Mumbai / Delhi / Pune / Bangalore / Hyderabad / Chennai / Kolkata / Kochi / Ahmedabad / Chandigarh(May 12)

​​​​​​​US regulators expanded the use of Pfizers’ Covid-19 vaccine to children as young as 12 offering a way to protect the nations adolescents before they head back to school in the fall and paving the way for them to return to more normal activities.Read more

2. Sri Lanka approves Pfizer shot

The Hindu - Delhi / Mumbai / Bangalore / Hyderabad / Chennai / Kolkata / Kochi / Chandigarh(May 09)

Sri Lanka on Saturday approved Pfizers’ COVID-19 vaccine for emergency use in Sri Lanka as the island nation battles a third wave of the virus while suffering a restricted supply of vaccines from neighbouring India.Read more

3. Pfizer's Covid jab provides 95% protection, says study

Hindustan Times - Delhi / Mumbai / Pune / Chandigarh / Faridabad / Gurgaon / Noida(May 07)

The largest real-world study yet of the Pfizer-BioNTech vaccine on Thursday confirmed that the jab provided more than 95% protection against Covid-19 but found that the level dropped when people received just one of the two prescribed doses.Read more

4. pfizer donates $70 mn supplies to india to aid covid treatment

Hindustan Times - Delhi / Mumbai / Chandigarh / Gurgaon(May 04)

Rhythma Kaul

US pharma giant Pfizer has donated medical supplies worth $70 million including drugs to treat the coronavirus disease (Covid-19) to India the company said in a statement on Monday adding that it was in talks with the Indian government to expedite its Covid-19 vaccine approval. Read more

5. Pfizer in talks with govt over 'expedited nod' for vaccine

The Indian Express - Delhi / Mumbai / Pune / Kolkata / Ahmedabad / Chandigarh(May 04)

PFIZER CHIEF Albert Bourla said on Monday the firm is donating medicines worth $70 million for treatment of Covid patients in India. We are deeply concerned by the critical Covid situation in India and our hearts go out to you your loved ones and all the people of India he said.Read more

6. Pfizer, Moderna vaccines could be soon in India

The Times Of India - Delhi(May 04)

Meanwhile the government said it has placed orders for 16 crore Covishield and Covaxin vaccines to be supplied in May-July. Adar Poonawalla said SII has govt orders to supply 11 crore more doses over the next few months. PII Read more

7. Pfizer donates USD 70 mn worth Covid-19 treatment drugs to India

(May 03)

sign in - Pfizer donates USD 70 mn worth Covid-19 treatment drugs to India Global pharma major Pfizer is sending its ... now Pfizer colleagues at distribution centres in the US Europe and Asia are hard at work rushing shipments of Pfizer... Read more

8. Confident Pfizer shot works against Indian variant: BioNTech co-founder

Hindustan Times - Delhi / Mumbai / Faridabad / Gurgaon / Noida(April 29)

BioNTech co-founder Ugur Sahin on Wednesday voiced confidence that the vaccine that his company jointly developed with Pfizer works against the Indian variant of the coronavirus. Read more

9. Pfizer offers vaccine to India govt at not-for-profit price

Hindustan Times - Mumbai(April 23)

Rhythma Kaul

People wait in a queue outside a Covid-19 vaccination centre in Goregaon Mumbai on Thursday. Read more

10. Pfizer: Will supply only through govt channels

The Indian Express - Delhi / Faridabad / Gurgaon / Noida(April 22)

PRABHA RAGHAVAN

PFIZER HAS decided to prioritise orders from the government, and supply doses of its Covid-19 vaccine “only through govern­ment contracts” in India. Read more

11. Pfizer vaccine is 'extraordinarily effective' against variants: Studies

Business Standard - Mumbai / Delhi / Bangalore / Kolkata / Chandigarh(May 08)

EMILY ANTHES

The studies, which are based on the real-world use of the vac­cine in Qatar and Israel, suggest that the vaccine can prevent the worst outcomes — including severe pneumonia and death — caused by B.l.1.7, the variant first identified in the UK, and B.1.351, the variant first identified in South Africa. Read more

VIEW ALL

Media Contacts

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

Email us at: Contactus.India@Pfizer.com
Call us at: +91 - 022 - 6693 2000

If you are not a journalist, please visit Contact Us to reach the appropriate Pfizer contact.

  • COMPANY FACT SHEET
  • LOGOS
  • VALUES
  • CSR
  • COMPANY HISTORY
About UsOur ScienceOur Community EffortsYour Health Career-Seekers News & MediaHealthcare ProfessionalsContact UsTerms And ConditionsPrivacy PolicyAdverse Event ReportingCopyright © 2002- 2022 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of  India and strictly only for informational, educational, academic and/or research purposes and is not intended to substitute for professional medical advice, diagnosis or treatment. While due care and caution has been taken to ensure that the content here is free from mistakes or omissions, Pfizer makes no claims, promises or guarantees about the accuracy, completeness or adequacy of the information here. You may report an adverse event related to Pfizer products by emailing us at IND.AEReporting@pfizer.com or via Fax at: 000800100-5961 / +91-22 3919-771.